Description

3β-[(2,6-Dideoxy-3-o-Methyl-β-D-Lyxo-Hexopyranosyl)Oxy]-14-Oxo-8,15-Cyclo-14,15-Seco-5β-Card-20(22)-Enolide is a complex steroidal glycoside derivative, representing a high-value intermediate in advanced organic synthesis. This compound is of significant interest for its structural framework, which is pivotal in the research and development of novel bioactive molecules. It is primarily utilized by pharmaceutical R&D laboratories, academic research institutions, and specialty chemical manufacturers focused on steroid chemistry and cardiac glycoside analogs.

Application

• Pharmaceutical Research & Development: Serves as a key synthetic intermediate or reference standard in the discovery and development of novel therapeutic agents, particularly those targeting cardiovascular pathways.
• Academic & Industrial Chemical Synthesis: Used as a sophisticated building block in complex organic synthesis, enabling the construction of structurally related steroidal compounds for structure-activity relationship (SAR) studies.
• Reference Standard for Analytical Methods: Employed as a high-purity standard in analytical laboratories for method development, validation, and quality control (QC) of related compounds using techniques like HPLC and LC-MS.
• Biochemical Research: Investigated for its biological activity and interaction with enzymes or receptors in biochemical and pharmacological studies related to cardiac glycosides.
• Process Chemistry Development: Acts as a critical intermediate in scaling up synthetic routes for potential active pharmaceutical ingredients (APIs) within regulated environments.

Basic Information

Item	Details
Product Name	3β-[(2,6-Dideoxy-3-o-Methyl-β-D-Lyxo-Hexopyranosyl)Oxy]-14-Oxo-8,15-Cyclo-14,15-Seco-5β-Card-20(22)-Enolide
CAS No.	69686-84-6
Molecular Formula	C30H42O8
Molecular Weight	530.65 g/mol
Synonyms	3β-[(2,6-Dideoxy-3-O-methyl-β-D-lyxo-hexopyranosyl)oxy]-14-oxo-8,15-cyclo-14,15-seco-5β-card-20(22)-enolide; 8,15-Cyclo-14,15-secocard-20(22)-enolide derivative; 3-O-(2,6-Dideoxy-3-O-methyl-β-D-lyxo-hexopyranosyl)-14-oxo-8,15-cyclo-14,15-seco-5β-card-20(22)-enolide; Steroidal glycoside intermediate; Cardiac glycoside analog; 69686-84-6; 3β-[(2,6-Dideoxy-3-O-methyl-β-D-lyxo-hexopyranosyl)oxy]-14-oxo-8,15-cyclo-14,15-seco-5β-card-20(22)-enolide
EINECS	Contact for details

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards. We employ advanced analytical techniques including HPLC, GC, NMR, and MS to verify identity, purity, and potency. A comprehensive Certificate of Analysis (COA) is provided with each batch, detailing all critical quality attributes. Our quality management system supports the supply of material suitable for research and development under GMP-like controls where required.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed after opening to minimize exposure to atmospheric moisture. For long-term storage, consider the use of desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 5.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 5.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.